(Q45304699)

11 December 2017

title

Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model (English)

1 reference

11 December 2017

0 references

0 references

Schilling G

1

1 reference

11 December 2017

Coonfield ML

series ordinal

2

1 reference

11 December 2017

Ross CA

series ordinal

3

1 reference

11 December 2017

Borchelt DR

series ordinal

4

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

11 December 2017

1 reference

11 December 2017

volume

315

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

149-153

1 reference

Mitochondrial dysfunction in neurodegenerative diseases

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

Mitochondrial defect in Huntington's disease caudate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

Huntington's disease and dentatorubral-pallidoluysian atrophy: proteins, pathogenesis and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902326-6

7 January 2021

10.1016/S0304-3940(01)02326-6

Identifiers

DOI

1 reference

11 December 2017

1 reference